NVIDIA Corporation NVDA
Set alert
202.06 USD -2.58 -1.26%
At close
205.15 +3.09 +1.53%
Pre-market · Nov 3, 5:45 AM ET
201.66 Day range 209.98
164.27 52-week range 243.37
- YTD
- +8.34%
- 1 year
- -0.21%
- Open
- 207.53
- Prev close
- 204.64
- Mkt cap
- 4.88T
- Vol
- 119.22M
- Avg vol
- 114.13M
- EPS
- 7.91
- P/E
- 25.54
- Div yield
- 0.47%
More statistics
- Low
- 201.66
- High
- 209.98
- Forward P/E
- 12.70
- Beta
- 2.25
- Short ratio
- 2.84
- Inst. own
- 71.52%
- Dividend
- 1.00
- Ex-div date
- Sep 9, 2026
- Earnings
- Nov 17, 2026
- 50-d avg
- 221.75
- 200-d avg
- 204.38
- 1y target
- 328.95
5Y chart
Events in this range
- Dec 1, 2021Dividend: 0.04
- Dec 2, 2021Dividend: 0.04
- Mar 2, 2022Dividend: 0.04
- Jun 8, 2022Dividend: 0.04
- Sep 7, 2022Dividend: 0.04
- Sep 8, 2022Dividend: 0.04
- Nov 30, 2022Dividend: 0.04
- Dec 22, 2022Dividend: 0.04
- Mar 7, 2023Dividend: 0.04
- Jun 7, 2023Dividend: 0.04
- Sep 6, 2023Dividend: 0.04
- Dec 5, 2023Dividend: 0.04
- Mar 5, 2024Dividend: 0.04
- May 29, 2024Dividend: 0.04
- Jun 10, 2024Split: 10 for 1
- Jun 11, 2024Dividend: 0.01
- Sep 12, 2024Dividend: 0.01
- Dec 5, 2024Dividend: 0.01
- Mar 12, 2025Dividend: 0.01
- Jun 11, 2025Dividend: 0.01
- Aug 27, 2025Earnings: 1.05; estimate 1.01; surprise 3.96%
- Sep 11, 2025Dividend: 0.01
- Nov 19, 2025Earnings: 1.3; estimate 1.26; surprise 3.17%
- Dec 4, 2025Dividend: 0.01
- Feb 25, 2026Earnings: 1.62; estimate 1.54; surprise 5.19%
- Mar 11, 2026Dividend: 0.01
- May 20, 2026Earnings: 1.87; estimate 1.76; surprise 6.25%
- Jun 4, 2026Dividend: 0.25
- Aug 26, 2026Earnings: 2.22; estimate 2.09; surprise 6.22%
- Sep 4, 2026Rating: Rosenblatt · Buy → Buy
- Sep 10, 2026Dividend: 0.25
- Sep 10, 2026Rating: Piper Sandler · — → Overweight
- Sep 29, 2026Rating: Rosenblatt · Buy → Buy
- Oct 1, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
- Oct 22, 2026Rating: Needham · Buy → Buy
- Nov 2, 2026Rating: Melius Research · Buy → Buy
Signals (85)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 16, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
Newest 20 of 85.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 328.95 +62.8% upside
Now 202.06
- Target (low)
- 180.00
- Target (mean)
- 328.95
- Target (high)
- 515.00
Ratings (0m) 62 59 buy · 2 hold · 1 sell
- Strong buy10
- Buy49
- Hold2
- Sell1
- Strong sell0
Recommendation trend
- This month 62
- 1 month ago 62
- 2 months ago 60
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.47 | 2.34 – 2.70 | 1.30 | +90.3% | 108.98B | +91.2% | 44 |
| Next quarter | 2.75 | 2.56 – 3.12 | 1.62 | +69.5% | 124.48B | +82.7% | 42 |
| Current year | 9.31 | 9.01 – 10.10 | 4.77 | +95.2% | 411.65B | +90.6% | 51 |
| Next year | 15.91 | 12.85 – 18.75 | 9.31 | +70.9% | 692.21B | +68.2% | 52 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Melius Research | Maintained | Buy | Buy |
| Oct 22, 2026 | Needham | Reiterated | Buy | Buy |
| Oct 1, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Sep 29, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Sep 10, 2026 | Piper Sandler | Initiated | — | Overweight |
| Sep 4, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Sep 4, 2026 | Needham | Reiterated | Buy | Buy |
| Aug 27, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 27, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 27, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 27, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Aug 27, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 27, 2026 | UBS | Maintained | Buy | Buy |
| Aug 27, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 27, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Aug 27, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 27, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 27, 2026 | DA Davidson | Maintained | Buy | Buy |
| Aug 27, 2026 | Benchmark | Reiterated | Buy | Buy |
| Aug 27, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 27, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Aug 27, 2026 | Keybanc | Reiterated | Overweight | Overweight |
| Aug 27, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 27, 2026 | Needham | Maintained | Buy | Buy |
| Aug 27, 2026 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Aug 25, 2026 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Aug 24, 2026 | Rosenblatt | Maintained | Buy | Buy |
| Aug 24, 2026 | Keybanc | Reiterated | Overweight | Overweight |
| Aug 24, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 21, 2026 | BMO Capital | Initiated | Outperform | Outperform |